Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Effects of Dietary Phosphorus Bioaccessibility and Calcitriol on Phosphorus and Calcium Whole-Body Balance and Kinetics in Moderate CKD
Hill Gallant, K. (PI), Freese, R. L. (CoI), Nachman, P. (CoI) & Zheng, X. (CoI)
NIH NATL INST OF DIABETES/DIG/KIDNEY DIS
4/1/24 → 1/31/29
Project: Research project
-
A Phase 1/2, Open-Label, Single-Arm and Randomized Parallel-Group Study to Investigate the Safety andEfficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) Compared withBelimumab in Subjects with Active Systemic Lupus Erythem
Nachman, P. (PI)
3/26/24 → 3/25/33
Project: Research project
-
Minnesota Precision Medicine CKD & Resilient Diabetes Recruiting Site: Engagement, Enrollment & Ethics
Nachman, P. (PI), Adeyi, O. (CoI), Berge, J. M. (CoI), Bu, L. (CoI), Caramori, L. (Co-Principal Investigator), Caramori, L. (CoI), Drawz, P. E. (CoI), Flanagan, S. M. (CoI), Harindhanavudhi, T. (CoI), Ma, S. (CoI), Rosenberg, M. (CoI), Safadi, S. (CoI) & Wolf, S. M. (CoI)
NIH NATL INST OF DIABETES/DIG/KIDNEY DIS
9/15/22 → 6/30/27
Project: Research project
-
NEPTUNE Public-Private Partnership ("MATCH Study")
Nachman, P. (PI) & Rheault, M. N. (Prior Principal Investigator)
UNIVERSITY OF MICHIGAN, TRAVERE THERAPEUTICS, INC
7/1/21 → 6/30/25
Project: Research project
-
Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Results of an International Randomized Controlled Trial (PEXIVAS)
the PEXIVAS Investigators, May 1 2024, In: American journal of respiratory and critical care medicine. 209, 9, p. 1141-1151 11 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Molecular Signatures of Glomerular Neovascularization in a Patient with Diabetic Kidney Disease
Kidney Precision Medicine Project, Feb 2024, In: Clinical Journal of the American Society of Nephrology. 19, 2, p. 266-275 10 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis
Mariani, L. H., Trachtman, H., Thompson, A., Gillespie, B. S., Denburg, M., Diva, U., Geetha, D., Greasley, P. J., Hladunewich, M. A., Huizinga, R. B., Inrig, J. K., Komers, R., Laurin, L. P., Little, D. J., Nachman, P. H., Smith, K. A., Walsh, L. & Gibson, K. L., 2024, (Accepted/In press) In: American Journal of Kidney Diseases.Research output: Contribution to journal › Article › peer-review
-
Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today
NEPTUNE investigators, Feb 2024, In: Kidney international. 105, 2, p. 218-230 13 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Risk of Relapse of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids
for the PEXIVAS Investigators, Sep 2024, In: Arthritis and Rheumatology. 76, 9, p. 1431-1438 8 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations